Provided by Tiger Trade Technology Pte. Ltd.

LifeStance Health Group, Inc.

11.91
-0.1200-1.00%
Post-market: 11.910.00000.00%19:30 EDT
Volume:3.71M
Turnover:44.41M
Market Cap:4.55B
PE:92.44
High:12.25
Open:12.04
Low:11.84
Close:12.03
52wk High:13.56
52wk Low:4.77
Shares:382.06M
Float Shares:275.73M
Volume Ratio:0.85
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1288
EPS(LYR):0.0200
ROE:3.43%
ROA:2.32%
PB:3.08
PE(LYR):595.50

Loading ...

Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 05, 2023

Correspondence

Form CORRESP - Correspondence
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2023

Correspondence

Form CORRESP - Correspondence
Aug 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]